Bookmark

Add to MyYahoo RSS

Alzheimer's News

News on Alzheimer's continually updated from thousands of sources around the net.

2 hrs ago | WKOW-TV

Wisconsin families share their struggles with Alzheimer's Disease

Nearly one in three seniors who dies each year in the United States has Alzheimer's Disease. The cost of care is $214 billion.

Comment?

Related Topix: Health, Janesville, WI

6 hrs ago | Northern Michigan News

Overcoming the emotional effects of Alzheimer's disease

A walk down memory lane can be an emotionally painful journey for those unable to share those moments with loved ones moving through the stages of Alzheimer's disease. Jackie Kivve, a resident care manager at Sunnyside Senior Living, said the symptoms of Alzheimer's disease are subtle at first, but the effects of memory loss often drastically change the dynamics between the patient and caregiver.

Comment?

Related Topix: Health, Medicine, Dementia, Depression, Long Term Care

10 hrs ago | Daily Texan

Alzheimer's research fund awards UT professor grant for study

A UT professor received a $165,000 grant from the Darrell K Royal Research Fund for Alzheimer's Disease for a research study that focuses on improving the memory of patients with cognitive impairments. Psychology associate professor Marie Monfils will begin her research by testing rodents with mild cognitive impairments, hoping to improve their memory using a reconsolidation-update technique.

Comment?

Related Topix: Health, University of Wisconsin Milwaukee

Tue Sep 16, 2014

Steuben Courier

Common Sleeping & Anxiety Pills Linked to Alzheimer's

Commonly-prescribed sleeping and anxiety pills, also known as benzodiazepines, are now under scrutiny. In a recent study, researchers found that those who take drugs like Xanax and Valium have a significantly higher risk of developing Alzheimer's disease.

Comment?

Related Topix: Anxiety, Medicine, Health

KLEW-TV Lewiston

Learn how to reduce your risk of Alzheimer's at Wedgewood Terrace seminar

National Alzheimer's Disease Awareness Month isn't until November, but leaders from a nursing home in Lewiston are getting a head start on awareness. Mark Havens, Community Relations Director at Wedgewood Terrace said Alzheimer's disease is the sixth leading killer of Americans, and that number is growing.

Comment?

Related Topix: Health, Lewiston, ID

Go Local

Health | UMass Medical School Study Questions Alzheimer's Treatments

More than half of the people in nursing homes who are in end stages of Alzheimer's disease are prescribed medications with questionable benefits, according to a recently published UMass Medical School Study. These treatments - such as medication to treat dementia and to lower cholesterol not only drive up medical costs, but also put patients' health at risk since may have troubles swallowing pills and communicating side effects to healthcare providers.

Comment?

Related Topix: Health, Dementia, Worcester, MA

Missourian

from Readers: Homecoming queen candidate raises money for Alzheimer's Association

Tristen Shaw is raising money for the Alzheimer's Association in honor of her Grandma Joy, who has the disease. Tristen Shaw is a senior at Hickman High School and is running for Homecoming queen.

Comment?

Related Topix: Health

WFMZ

Adult center donates to Alzheimer's research

A local group says it is doing its part to help those affected by Alzheimer's. Monday officials from Sarah-Care Adult Day Center presented a check for more than $1,200 to the Alzheimer's Association.

Comment?

Related Topix: Health

Reuters

AstraZeneca gets up to $500 million from Lilly for Alzheimer's drug

AstraZeneca has signed a partnership deal with U.S. rival Eli Lilly that could earn the British company up to $500 million if a promising - but risky - experimental Alzheimer's drug proves successful. AstraZeneca said in May that it was looking to find a partner for its so-called BACE inhibitor drug called AZD3293, which is set to enter late-stage Phase III clinical testing against Alzheimer's.

Comment?

Mon Sep 15, 2014

Globe and Mail

Using big data to fight dementia and Alzheimer's

Scientists striving to cure Alzheimer's disease and other brain disorders are turning to a powerful new tool they hope will light the way to effective treatments: big data. The idea is to use supercomputers to search through reams of patient data - everything from MRI scans to the results of cognitive testing to lipid levels - for patterns that might reveal the precise cause of neurodegenerative disorders, which have so far proved stubbornly difficult to predict, halt or even slow down.

Comment?

Related Topix: Medicine, Dementia, Health, Science / Technology, High Performance Computing, Genetics

Evening Sun

APNewsBreak: NY bid to halt Alzheimer's drug swap

New York's attorney general filed a federal lawsuit Monday seeking to stop a manufacturer from discontinuing its drug widely used to treat Alzheimer's patients, arguing the company is illegally driving patients to its newer patented drug to avoid losses from cheaper generic alternatives coming out next year. Attorney General Eric Schneiderman alleges anti-trust and state law violations by Dublin-based Actavis PLC and New York subsidiary Forest Laboratories, which Actavis recently acquired for $28 billion.

Comment?

Related Topix: Healthcare Law, Law, Forest Laboratories, Biotech, Medicine, Forest Labs, Healthcare Industry

SFGate

APNewsBreak: NY bid to halt Alzheimer's drug swap

New York's attorney general filed a federal lawsuit Monday seeking to stop a manufacturer from discontinuing its drug widely used to treat Alzheimer's patients, arguing the company is illegally driving patients to its newer patented drug to avoid losses from cheaper generic alternatives coming out next year. The company says its new drug - which is taken once daily instead of twice - is better, that a majority of caregivers surveyed recommend it and that demand has been growing.

1 comment

Related Topix: Health, Science / Technology

ABC News

APNewsBreak: NY Bid to Halt Alzheimer's Drug Swap

New York's attorney general filed a federal lawsuit Monday seeking to stop a manufacturer from discontinuing its drug widely used to treat Alzheimer's patients, arguing the company is illegally driving patients to its newer patented drug to avoid losses from cheaper generic alternatives coming out next year. Attorney General Eric Schneiderman alleges anti-trust and state law violations by Dublin-based Actavis PLC and New York subsidiary Forest Laboratories, which Actavis recently acquired for $28 billion.

Comment?

Related Topix: Healthcare Law, Law, Forest Laboratories, Biotech, Medicine, Forest Labs, Healthcare Industry

13WHAM

Man walks 85 miles for Alzheimer's

A Henrietta man walked 85 miles over the course of four days from Buffalo to Rochester in honor of his wife, who was diagnosed with Alzheimer's. The walk began Friday morning.

2 comments

Related Topix: Health, Henrietta, NY, Buffalo, NY, North Tonawanda, NY, Tonawanda, NY

WebMD

Not Everyone With Alzheimer's-Linked Protein Develops Dementia: Study

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

Comment?

Related Topix: Health, WebMD, UC Berkeley

Reuters

Avanir's drug succeeds in reducing Alzheimer's related agitation

Avanir Pharmaceuticals Inc said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. Avanir said on Monday based on the data it planned to request a meeting with both the U.S. Food and Drug Administration and the European Medicines Agency.

Comment?

Related Topix: Health, Food and Drug Administration

Medical News Today

Brain may 'work around' early Alzheimer's damage

One of the hallmarks of Alzheimer's disease - the most common form of dementia - is the build-up of beta-amyloid protein deposits in the brain. Now a new study published in the journal Nature Neuroscience suggests that in some older people, the brain has a way of compensating for this damage by recruiting extra brain circuits.

Comment?

Related Topix: Health, Berkeley, CA, UC Berkeley

Examiner.com

Teen invents wearable gadget to track Alzheimer patients

Anyone who has been around someone that is suffering from Alzheimer's knows how frustrating it can be to care for them. The biggest issue is worrying about them wandering off and getting lost, and it is extremely hard to know when they move around at night while others sleep.

Comment?

Related Topix: Health, HarperCollins Publishers, Publishing, Media, Television, Ottaway Newspapers, Fox Filmed Entertainment, Digital Journal, FOX News Network

Sun Sep 14, 2014

The York Daily Record

NFL: 3 in 10 ex-players face Alzheimer's, dementia

The NFL estimates that nearly three in 10 former players will develop debilitating brain conditions, and that they will be stricken earlier and at least twice as often as the general population. The disclosure Friday comes in separate actuarial data the league and players' lawyers released as part of their proposed $765 million settlement of thousands of concussion lawsuits.

Comment?

New Scientist

Brains can power up to get around Alzheimer's plaques

It's one of the biggest mysteries of Alzheimer's. The disease is associated with the formation of protein plaques in the brain, but why is it that some people with plaques seem not to have the disease? Research suggests that some people's brains are able to reorganise during the early stages of Alzheimer's, delaying the appearance of initial symptoms.

Comment?

Related Topix: Health, Medicine, Dementia, Family, Elderly (Senior Citizen)

•••
•••
•••
•••
•••
•••
•••